Showing results (151-160 of 199) with videos related to

Sort By:
Pageof 20
Leukemia & Lymphoma|September 14, 2017
Treatment and prognosis of stage I follicular lymphoma in the modern era - does PET matter?Ohad S Bentur, Ronit Gurion, Anat Gafter-Gvili, et al.
Communications Biology|January 17, 2020
Discovery of tumoricidal DNA oligonucleotides by response-directed in vitro evolutionNoam Mamet, Yaniv Amir, Erez Lavi, et al.
Leukemia Research|January 16, 2021
Characteristics and outcome of multiple myeloma patients presenting with anaemia only: A retrospective multi-centre studyTamir Shragai, Moshe E Gatt, Adir Shaulov, et al.
British Journal of Haematology|July 1, 2021
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myelomaIrit Avivi, Roi Balaban, Tamir Shragai, et al.
Haematologica|July 8, 2021
Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients - a matched control multicenter cohort studyRon Ram, Sigal Grisariu, Liat Shargian-Alon, et al.
American Journal of Infection Control|November 27, 2013
Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trialIlana Oren, Hannah Sprecher, Renato Finkelstein, et al.
British Journal of Haematology|September 18, 2020
Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and PregnancyCharlotte Maggen, Daan Dierickx, Elyce Cardonick, et al.
Leukemia & Lymphoma|September 8, 2022
Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas: a report of the Israeli Myeloma Study GroupChezi Ganzel, Svetlana Trestman, Shai Levi, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 20, 2022
The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patientsEsther Saiag, Ayelet Grupper, Irit Avivi, et al.
Blood Advances|February 5, 2024
Outcomes of subsequent antilymphoma therapies after second-line axicabtagene ciloleucel or standard of care in ZUMA-7Armin Ghobadi, Javier Munoz, Jason R Westin, et al.
Pageof 20